Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AR | P10275 | 17/20 | 0.43 |
| ▸ | ALOX5AP | P20292 | 2/20 | 0.38 |
| ▸ | FEN1 | P39748 | 2/20 | 0.38 |
| ▸ | PGR | P06401 | 3/20 | 0.38 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.35 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21116265 | 0.95 | AR (0.44) | ARALOX5APFEN1PGR | |
| SCHEMBL21116272 | 0.91 | AR (0.43) | ARALOX5APFEN1PGRCYP11B1 | |
| SCHEMBL21258698 | 0.90 | AR (0.40) | ARALOX5APFEN1PGR | |
| SCHEMBL21116271 | 0.88 | AR (0.44) | ARALOX5APFEN1PGR | |
| SCHEMBL20114996 | 0.88 | AR (0.41) | ARALOX5APFEN1PGR | |
| SCHEMBL21116257 | 0.88 | CYP11B1 (0.41) | ARALOX5APFEN1PGRCYP11B1 | |
| SCHEMBL21258840 | 0.87 | ALOX5AP (0.40) | ARALOX5APFEN1PGR | |
| SCHEMBL21131809 | 0.87 | AR (0.42) | ARALOX5APFEN1PGR | |
| SCHEMBL20849062 | 0.87 | AR (0.39) | ARALOX5APFEN1PGR | |
| SCHEMBL21258835 | 0.87 | ALOX5AP (0.39) | ARALOX5APFEN1PGR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11136294-B2 | Organic molecules for use in optoelectronic devices | CYNORA GMBH (DE) | 2021-10-05 | — | — | US | disclosed |
| EP-3478656-B1 | DICARBAZOLE DIPHENYL DERIVATIVES FOR USE IN OPTOPELECTRONIC DEVICES | CYNORA GMBH (DE) | 2021-09-08 | — | — | EP | disclosed |
| US-20190194130-A1 | ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES | CYNORA GMBH (DE) | 2019-06-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190194130-A1 | ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES | OR10J3, NOX3, ORC3 | AR 1096/4885ALOX5AP 4470/4885FEN1 3270/4885 |
| US-11136294-B2 | Organic molecules for use in optoelectronic devices | OR10J3, ORC3, NOX3 | AR 1080/4885ALOX5AP 4497/4885FEN1 3029/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.